ABVC BioPharma, Inc. (ABVC)

SG&A Expense Growth

-67.27%

Quarterly · Period ending:

ABVC logo

ABVC SG&A Expense Growth

Latest reported-67.27%
ABVC Quarterly SG&A Growth (QoQ) (0.00% → -67.27%)
High-resolution chart · PNG

ABVC sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

ABVC BioPharma, Inc. SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-67.2738%
-29.0564%
12.1678%
-14.4686%
240.5447%
118.365%
-53.4572%
-30.7896%
-65.9155%
58.0771%
-12.3735%
24.0185%
-1.6296%
-16.3987%
-43.0317%
89.2632%
-69.0881%
-4.2837%
240.3804%
5.7574%
22.5428%
-70.5278%
274.5547%
-1.1751%
10.7328%
21.1993%
-7.3404%
82.174%
11.548%
36.4381%
11.7745%
-27.5434%
10.3037%
35.0301%
-53.4702%
283.7631%
-18.7594%
14.3114%
-71.4091%
124.0476%
165.8812%
3,172.1035%
0%
0%
0%
-100%
0%
0%
0%
0%
0%
0%
0%
0%
-100%
-47.253%
-26.5608%
-27.5056%
10.395%
-45.9996%
134.7512%
-11.1187%
7.9681%
0.458%
-20.6474%
-45.3902%
3.9156%
10.3493%
-17.5693%
-68.2785%
148.5982%
-19.5577%
-15.3159%
6.8635%
-67.1951%
32,588.902%
11.631%
25.5949%
622.9619%
-82.3195%
-8.4504%
1,820.8333%
-107.2224%
61.8213%
-43.7474%
47.6142%
-33.6997%
1.8152%
117.7415%
-66.35%
0%
0%
0%
0%
-100%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.